Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Morphine sulfate 30mg/30ml solution for infusion vials
0407020Q0AAFPFP
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 30mg/5ml oral solution
0407020Q0AAETET
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 30mg/5ml soln unit dose vials sugar free
0407020Q0AACTCT
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 3mg/5ml oral solution
0407020Q0AAFIFI
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 40mg/5ml oral solution
0407020Q0AAFEFE
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 4mg/10ml solution for injection ampoules
0407020Q0AAA5A5
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 50mg suppositories
0407020Q0AABVBV
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 50mg/5ml oral solution
0407020Q0AADKDK
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 50mg/5ml solution for injection ampoules
0407020Q0AAFWFW
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 5mg suppositories
0407020Q0AABJBJ
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 5mg/10ml solution for injection ampoules
0407020Q0AAA8A8
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 5mg/1ml solution for injection ampoules
0407020Q0AAA2A2
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 60mg suppositories
0407020Q0AABNBN
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 60mg/5ml oral solution
0407020Q0AAESES
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 750mg suppositories
0407020Q0AAEPEP
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 75mg/5ml oral solution
0407020Q0AAECEC
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate 80mg/5ml oral solution
0407020Q0AAFAFA
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine sulfate powder
0407020Q0AAANAN
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine tartrate 15mg/1ml / Cyclizine tartrate 50mg inj amp
040702020AAABAB
|
Morphine tartrate/cyclizine tartrate | Morphine tartrate and cyclizine tartrate | Central Nervous System | No data available |
|
Morvesin XL 400microgram capsules
0704010U0BLAAAA
|
Morvesin | Tamsulosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Motherwort herb tincture
190606000BCTKA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Motilium 10 tablets
0406000J0BBAFAJ
|
Motilium | Domperidone | Central Nervous System | No data available |
|
Motilium 1mg/ml oral suspension
0406000J0BBABAC
|
Motilium | Domperidone | Central Nervous System | No data available |
|
Motilium 30mg suppositories
0406000J0BBACAB
|
Motilium | Domperidone | Central Nervous System | No data available |
|
Motilium Instants 10mg orodispersible tablets
0406000J0BBAGAN
|
Motilium | Domperidone | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.